Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICG
London, England, United Kingdom
- Ownership
- Private
- Employees
- ~793
- Development stage
- Other
01
Overview
ICG Life Sciences invests in and helps build innovative health and biotech companies, with portfolio companies advancing clinical programs (e.g., cell therapies for cancer, small molecules for neurodegenerative and neuropsychiatric disorders) through early to late clinical trials.[3][4][1][2]
- Therapeutic areas
- OncologyNeurologyEndocrinologyPsychiatry
- Modalities
- Small moleculeCell therapyCAR-T cell therapyAntibodyGene therapy
- Industry
- Investors
02
Partnerships
SV Health InvestorsAccess BiotechnologyRA Capital Management
Beyond the preview
Go deeper on ICG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ICG.